Cargando…
Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis
Based on a large cohort of clinical studies involving a total of 8024 patients and reporting the effects of HER4 on breast cancer prognosis, we conducted the first meta-analysis and review of this type. We identified 26 studies published between 1985 and 2016 and assessed the prognostic value of HER...
Autores principales: | Wang, Jue, Yin, Jun, Yang, Qing, Ding, Feng, Chen, Xiao, Li, Bingjie, Tian, Xingsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363541/ https://www.ncbi.nlm.nih.gov/pubmed/27736797 http://dx.doi.org/10.18632/oncotarget.12485 |
Ejemplares similares
-
Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficking
por: Lanotte, Romain, et al.
Publicado: (2020) -
Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis
por: Tian, Wei-Jie, et al.
Publicado: (2016) -
Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis
por: Lu, Jun-Lin, et al.
Publicado: (2021) -
The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer: HER1–4 protein expression and prognosis in pancreatic cancer
por: Li, Qin, et al.
Publicado: (2016) -
Relative Prognostic Value of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Operable Oesophagogastric Cancer
por: Chan, David S. Y., et al.
Publicado: (2012)